This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Diagnosing the PAH Patient in Primary Care

Diagnosing the PAH Patient in Primary Care

Format

Patient Case Study

Time to Complete

30 minutes

Released

August 1, 2018

Expires

July 31, 2019
Add to Queue


Maximum Credits

0.50 / AMA PRA Category 1 CreditTM

Accredited Provider



Provided by Advancing Knowledge in Healthcare, AKH Inc.

Commercial Supporter

Supported by Actelion Pharmaceuticals

Program Description

Pulmonary arterial hypertension (PAH) is a rare, chronic condition characterized by elevated pulmonary vascular resistance, remodeling and occlusion of the pulmonary arterioles, right ventricular dysfunction, right heart failure, and death, if untreated. The development of several highly effective targeted therapies increases the importance of recognition and understanding of the condition. This multi-activity CME curriculum is designed to address the educational needs related to PAH. The activity is interactive and fast-paced. It allows learners to test their knowledge, to compare their responses to their peers and find out what the experts have to say about PAH.

Intended Audience

This activity is intended for physicians and other healthcare professionals who are involved in the management of patients with PAH.

Educational Objectives

After completing this activity, the participant will be better able to:

  • Review the pathophysiology, classification, and diagnosis of pulmonary hypertension (PH)
  • Discuss the risk factors, symptoms, clinical presentation, and diagnosis of PAH

Conflict Of Interest Disclosure Policy

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.

Faculty

Richard N. Channick, MD
Director of the Pulmonary Hypertension and Thromboendarterectomy Program
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Dr. Channick has disclosed the following relevant financial relationships:
Consultant: Actelion, Arena, Bayer
Contracted Research: Actelion, Bayer, Gilead

Vallerie V McLaughlin, MD, FACC, FAHA, FCCP
Kim A. Eagle MD Endowed Professor of Cardiovascular Medicine
Director of Pulmonary Hypertension Program
Associate Chief, Cardiovascular Medicine
Director, Heart Vessel Blood Clinical Trials Support Unit
Director, Disease Management Ambulatory Care Unit
Director, Inpatient Services University of Michigan
Ann Arbor, MI

Dr. McLaughlin has disclosed the following relevant financial relationships:
Consultant: Actelion, Arena, Bayer, Medtronic, Merck, United Therapeutics
Contract Research: Actelion, Eiger, Sonovie

Accredited Provider Disclosure

Margaret V. Clark, MSc, RN, RRT - NPS, CMPP, Medical Writer/Interviewer, discloses no financial relationships with pharmaceutical or medical product manufacturers.

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner, discloses no financial relationships with pharmaceutical or medical product manufacturers.

AKH Inc, planners and reviewers have disclosed no financial relationships with pharmaceutical or medical product manufacturers.

Credit

0.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit(s)TM  from organizations accredited by ACCME.

Disclosure of Unlabeled Use

This educational activity will include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

Instructions

There is no fee to participate in this activity. To obtain credit during the period August 1, 2018 through July 31, 2019, a score of 70% or better on the post-test is required. Participants must review all activity information, including the learning objectives, disclosure statements, and content. A statement of credit will be available to print from your CME History on myCME. Users must:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Successfully complete the post-test, activity evaluation, and claim credit. A post-test score of 70% or higher is required, and you may retake the post-test up to 2 times to achieve a passing score.
  • Your certificate will be available to print from your CME History, located under My Account.
If you have any questions relating to the accreditation of this activity, please contact tbrignoni@akhcme.com.

Privacy Policy

AKH Inc. Privacy Policy

When you register for a Continuing Medical Education (CME) or a Continuing Education (CE) activity through one of our Web sites, we collect certain personally identifiable information from you such as your name, email address and mailing address. If you are a pharmacist and wish to receive CE credit, you are also required to provide your NAPB # and month and day of birth. For more information about NABP and CPE Monitor click here. In addition to personally identifiable information, we collect aggregated non-personally identifiable information about the activities undertaken by our users. We use the information that we collect through CME/CE activities in several ways:

  • We work with several accredited companies who are accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. As a joint-provider, we are required periodically to submit aggregated data about CME participants and the CME activities we certify. We also provide personally identifiable information to other accredited CME/CE providers who certify CME/CE activities posted on our Web sites, as required by the ACCME and other accrediting bodies. These reports may include personally identifiable information about you and credits issued to you, for the purpose of maintaining records that you can request from the accredited provider for up to six (6) years.
  • Commercial supporters of CME/CE activities on our Web site will receive only aggregated data about CME/CE activities that are relevant to their interests and/or the courses they support.
  • Our Editorial and Customer Support Staff will have internal access to files containing personally identifiable information, including evaluation forms and aggregated CME /CE participant information. These files can be accessed in order to respond to your questions or comments. Our staff may also use personally identifiable information, including registration information and evaluation data, in assessing educational needs and planning marketing activities.

We may use the information we collect as otherwise permitted in this Privacy Policy.


myCME privacy policy
Add to Queue


Related to this activity

Treating the PAH Patient in Primary Care Patient Case Study

Treating the PAH Patient in Primary Care

CME 0.50 Credits